Drug Shortage Report for FRAXIPARINE
Report ID | 130817 |
Drug Identification Number | 02450631 |
Brand name | FRAXIPARINE |
Common or Proper name | Fraxiparine®(nadroparin calcium injection (0.6 mL)) |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | NADROPARIN CALCIUM |
Strength(s) | 9500UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 PF Syringe |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-12-21 |
Estimated end date | 2021-04-23 |
Actual end date | 2021-04-26 |
Shortage status | Resolved |
Updated date | 2021-04-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-01-04 | English | Compare |
v2 | 2021-01-04 | French | Compare |
v3 | 2021-03-22 | English | Compare |
v4 | 2021-03-22 | French | Compare |
v5 | 2021-04-21 | English | Compare |
v6 | 2021-04-21 | French | Compare |
v7 | 2021-04-26 | English | Compare |
v8 | 2021-04-26 | French | Compare |
v9 | 2021-04-27 | English | Compare |
Showing 1 to 9 of 9